Quick Answer
Vivani Medical, Inc. reported Research And Development Expense of $18.13 million for the year ending 2025.
- Vivani Medical, Inc. showed an increase of +15.1% in Research And Development Expense from 2024 to 2025.
- This data is from Vivani Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Vivani Medical, Inc.'s Research And Development Expense has grown by 457.9%.
- Historical annual values: Fiscal year 2025: $18.13 million | Fiscal year 2024: $15.75 million | Fiscal year 2023: $16.97 million | Fiscal year 2022: $14.17 million | Fiscal year 2021: $11.00 million | Fiscal year 2020: $4.84 million | Fiscal year 2019: $13.14 million | Fiscal year 2018: $10.01 million | Fiscal year 2017: $7.89 million | Fiscal year 2016: $5.35 million | Fiscal year 2015: $3.04 million | Fiscal year 2014: $5.04 million | Fiscal year 2013: $3.25 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: